C57BL/6JCya-Glrx2em1/Cya
Common Name
Glrx2-KO
Product ID
S-KO-13044
Backgroud
C57BL/6JCya
Strain ID
KOCMP-69367-Glrx2-B6J-VA
When using this mouse strain in a publication, please cite “Glrx2-KO Mouse (Catalog S-KO-13044) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Glrx2-KO
Strain ID
KOCMP-69367-Glrx2-B6J-VA
Gene Name
Product ID
S-KO-13044
Gene Alias
1700010P22Rik, Grx2
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 1
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000185362
NCBI RefSeq
NM_001038592
Target Region
Exon 1~4
Size of Effective Region
~7.4kb
Overview of Gene Research
Glrx2, encoding mitochondrial glutaredoxin2 (Grx2), is an important redox regulator [1,2,3,4,5]. It is involved in maintaining the balance of thiol-dependent redox systems and participates in multiple biological processes related to oxidative stress response, such as protecting cells from oxidative damage [1,2,3,4,5]. The Nrf2-mediated pathway is one of the associated pathways [1].
In gene knockout studies, mitochondrial Glrx2 knockout in mice sensitized them to acetaminophen-induced hepatotoxicity. Glrx2 deletion hindered Nrf2-mediated compensatory recovery of thiol-dependent redox systems, leading to a more oxidized cellular state and enhanced apoptosis-inducing factor (AIF) pathway-mediated oxidative damage [1]. In contrast, in male mice, ablating the Glrx2 gene protected against non-alcoholic fatty liver disease (NAFLD) by enhancing mitochondrial redox buffering capacity [2].
In conclusion, Glrx2 plays a crucial role in maintaining cellular redox homeostasis. Gene knockout mouse models have revealed its significance in diseases like acetaminophen-induced hepatotoxicity and NAFLD, highlighting its potential as a therapeutic target in these disease areas.
References:
1. Li, Jing, Tang, Xuewen, Wen, Xing, Du, Yatao, Lu, Jun. 2022. Mitochondrial Glrx2 Knockout Augments Acetaminophen-Induced Hepatotoxicity in Mice. In Antioxidants (Basel, Switzerland), 11, . doi:10.3390/antiox11091643. https://pubmed.ncbi.nlm.nih.gov/36139718/
2. Grayson, Cathryn, Chalifoux, Olivia, Russo, Mariana De Sa Tavares, Agellon, Luis B, Mailloux, Ryan J. 2024. Ablating the glutaredoxin-2 (Glrx2) gene protects male mice against non-alcoholic fatty liver disease (NAFLD) by limiting oxidative distress. In Free radical biology & medicine, 224, 660-677. doi:10.1016/j.freeradbiomed.2024.09.016. https://pubmed.ncbi.nlm.nih.gov/39278573/
3. Nagy, Norbert, Malik, Gautam, Tosaki, Arpad, Maulik, Nilanjana, Das, Dipak K. 2007. Overexpression of glutaredoxin-2 reduces myocardial cell death by preventing both apoptosis and necrosis. In Journal of molecular and cellular cardiology, 44, 252-60. doi:. https://pubmed.ncbi.nlm.nih.gov/18076901/
4. Diotte, Nicole M, Xiong, Ye, Gao, Jinping, Chua, Balvin H L, Ho, Ye-Shih. 2008. Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2. In Biochimica et biophysica acta, 1793, 427-38. doi:10.1016/j.bbamcr.2008.10.014. https://pubmed.ncbi.nlm.nih.gov/19038292/
5. Liu, Yuna, Gong, Jinlin, Wang, Qing, Zhao, Lei, Wu, Zhenan. 2023. Activation of the Nrf2/HO-1 axis by glutaredoxin 2 overexpression antagonizes vascular endothelial cell oxidative injury and inflammation under LPS exposure. In Cytotechnology, 76, 167-178. doi:10.1007/s10616-023-00606-x. https://pubmed.ncbi.nlm.nih.gov/38495299/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
